Mesothelioma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Immunological Variables Associated to ICI Toxicity in Cancer Patients
Conditions:   Breast Cancer;   Melanoma;   Non Small Cell Lung Cancer;   Non-melanoma Skin Cancer;   Gastrointestinal Cancer;   Head and Neck Cancer;   Renal Cell Carcinoma;   Small Cell Lung Cancer;   Mesothelioma, Malignant;   Bladder Cancer;   Merkel Cell Carcinoma;   Hepatoc ellular Carcinoma;   MSI-H Colorectal Cancer Intervention:   Drug: Checkpoint Blockade, Immune Sponsor:   Jules Bordet Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2022 Category: Research Source Type: clinical trials

OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition
Condition:   Malignant Pleural Mesothelioma Intervention:   Drug: OT-101 Sponsor:   Oncotelic Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2022 Category: Research Source Type: clinical trials